{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T03:41:51Z","timestamp":1785210111428,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-025-06170-7","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T03:22:43Z","timestamp":1768274563000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Second-look transurethral resection in high-grade Ta non-muscle invasive bladder cancer"],"prefix":"10.1007","volume":"44","author":[{"given":"Sophie","family":"R\u00e9gnier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Etienne","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idir","family":"Ouzaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Moschini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Soria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"D\u2019Andrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Budowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Poyet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Roumiguie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario \u00c1lvarez","family":"Maestro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Krajewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kees","family":"Hendricksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Veerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Afferi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino","family":"Mattei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Di Bona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Zamboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Simeone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronan","family":"Thenault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Verhoest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Gontero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evanguelos","family":"Xylinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"key":"6170_CR1","unstructured":"Cancer today [Internet] http:\/\/gco.iarc.fr\/today\/home"},{"issue":"1","key":"6170_CR2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.eururo.2015.06.045","volume":"69","author":"S Cambier","year":"2016","unstructured":"Cambier S, Sylvester RJ, Collette L, Gontero P, Brausi MA, van Andel G et al (2016) EORTC nomograms and risk groups for predicting Recurrence, Progression, and Disease-specific and overall survival in Non-Muscle-invasive stage Ta-T1 urothelial bladder cancer patients treated with 1\u20133 years of maintenance Bacillus Calmette-Gu\u00e9rin. Eur Urol Janv 69(1):60\u201369","journal-title":"Eur Urol Janv"},{"issue":"12","key":"6170_CR3","doi-asserted-by":"publisher","first-page":"e075942","DOI":"10.1136\/bmjopen-2023-075942","volume":"13","author":"T Lebret","year":"2023","unstructured":"Lebret T, Bonastre J, Fraslin A, Neuzillet Y, Droupy S, Rebillard X et al (2023) Cohort profile: coblance: a French prospective cohort to study prognostic and predictive factors in bladder cancer and to generate real-world data on treatment patterns, resource use and quality of life. BMJ Open 20 d\u00e9c 13(12):e075942","journal-title":"BMJ Open 20 d\u00e9c"},{"key":"6170_CR4","doi-asserted-by":"crossref","unstructured":"Gontero P, Birtle A, Capoun O, Comp\u00e9rat E, Dominguez-Escrig JL, Liedberg F et al European association of urology guidelines on Non-muscle-invasive bladder cancer (TaT1 and carcinoma in Situ)-A summary of the 2024 guidelines update. Eur Urol 17 ao\u00fbt 2024;S0302-2838(24)02514-4.","DOI":"10.1016\/j.eururo.2024.07.027"},{"issue":"3","key":"6170_CR5","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s11934-000-0020-6","volume":"1","author":"P Langenstroer","year":"2000","unstructured":"Langenstroer P, See W (2000) The role of a second transurethral resection for high-grade bladder cancer. Curr Urol Rep Oct 1(3):204\u2013207","journal-title":"Curr Urol Rep Oct"},{"issue":"1","key":"6170_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.euf.2023.07.002","volume":"10","author":"T Yanagisawa","year":"2024","unstructured":"Yanagisawa T, Kawada T, von Deimling M, Bekku K, Laukhtina E, Rajwa P et al (2024) Repeat transurethral resection for Non-muscle-invasive bladder cancer: an updated systematic review and Meta-analysis in the contemporary era. Eur Urol Focus Janv 10(1):41\u201356","journal-title":"Eur Urol Focus Janv"},{"issue":"2","key":"6170_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.eururo.2010.03.007","volume":"58","author":"RT Divrik","year":"2010","unstructured":"Divrik RT, Sahin AF, Yildirim U, Altok M, Zorlu F (2010) Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial. Eur Urol ao\u00fbt 58(2):185\u2013190","journal-title":"Eur Urol ao\u00fbt"},{"issue":"6","key":"6170_CR8","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.eururo.2018.02.014","volume":"73","author":"MGK Cumberbatch","year":"2018","unstructured":"Cumberbatch MGK, Foerster B, Catto JWF, Kamat AM, Kassouf W, Jubber I et al (2018) Repeat transurethral resection in Non-muscle-invasive bladder cancer: a systematic review. Eur Urol Juin 73(6):925\u2013933","journal-title":"Eur Urol Juin"},{"issue":"1","key":"6170_CR9","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00345-025-05778-z","volume":"43","author":"S Mebroukine","year":"2025","unstructured":"Mebroukine S, Klein C, Yacoub M, Capon G, Alezra E, Bladou F et al (2025) Utility of restaging transurethral resection in patients with primary high-grade Ta bladder cancer. World J Urol 23 Juin 43(1):387","journal-title":"World J Urol 23 Juin"},{"key":"6170_CR10","doi-asserted-by":"crossref","unstructured":"Abe S, Fujinami H, Yamanaka N, Hata S, Inoue T, Ando T et al (sept 2025) Is a second TUR necessary in patients with primary high-grade Ta NMIBC, particularly in the context of initial cases? BJUI compass. 6(9):e70082","DOI":"10.1002\/bco2.70082"},{"issue":"3","key":"6170_CR11","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","volume":"49","author":"RJ Sylvester","year":"2006","unstructured":"Sylvester RJ, van der Meijden APM, Oosterlinck W, Witjes JA, Bouffioux C, Denis L et al (2006) Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol Mars 49(3):466\u2013465 discussion 475\u2013477","journal-title":"Eur Urol Mars"},{"issue":"5","key":"6170_CR12","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.eururo.2009.05.047","volume":"57","author":"P Mariappan","year":"2010","unstructured":"Mariappan P, Zachou A, Grigor KM, Edinburgh Uro-Oncology Group (2010) Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience. Eur Urol Mai 57(5):843\u2013849","journal-title":"Eur Urol Mai"},{"issue":"8","key":"6170_CR13","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1089\/end.2020.0301","volume":"34","author":"W Krajewski","year":"2020","unstructured":"Krajewski W, Nowak \u0141, Poletajew S, Tukiendorf A, Moschini M, Mari A et al (2020) The impact of restaging transurethral resection of bladder tumor on survival parameters in T1 Nonmuscle-Invasive bladder cancer: systematic review and Meta-Analysis. J Endourol ao\u00fbt 34(8):795\u2013804","journal-title":"J Endourol ao\u00fbt"},{"issue":"1","key":"6170_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1159\/000490765","volume":"101","author":"M Ferro","year":"2018","unstructured":"Ferro M, Vartolomei MD, Cantiello F, Lucarelli G, Di Stasi SM, Hurle R et al (2018) High-Grade T1 on Re-Transurethral resection after initial High-Grade T1 confers worse oncological outcomes: results of a Multi-Institutional study. Urol Int 101(1):7\u201315","journal-title":"Urol Int"},{"issue":"1","key":"6170_CR15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4111\/icu.20210314","volume":"63","author":"K Lee","year":"2022","unstructured":"Lee K, Jeong SH, Yoo SH, Ku JH (2022) Evaluating the efficacy of secondary transurethral resection of the bladder for high-grade Ta tumors. Investig Clin Urol Janv 63(1):14\u201320","journal-title":"Investig Clin Urol Janv"},{"issue":"3","key":"6170_CR16","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.euo.2021.04.003","volume":"5","author":"PJ Hensley","year":"2022","unstructured":"Hensley PJ, Bree KK, Brooks N, Matulay J, Li R, Nogueras-Gonzalez GM et al (2022) Implications of Guideline-based, Risk-stratified restaging transurethral resection of High-grade Ta urothelial carcinoma on Bacillus Calmette-Gu\u00e9rin therapy outcomes. Eur Urol Oncol Juin 5(3):347\u2013356","journal-title":"Eur Urol Oncol Juin"},{"issue":"1","key":"6170_CR17","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/MOU.0000000000000949","volume":"32","author":"S Regnier","year":"2022","unstructured":"Regnier S, Califano G, Elalouf V, Albisinni S, Aziz A, Di Trapani E et al (2022) Restaging transurethral resection in Ta high-grade nonmuscle invasive bladder cancer: a systematic review. Curr Opin Urol 1 Janv 32(1):54\u201360","journal-title":"Curr Opin Urol 1 Janv"},{"issue":"4","key":"6170_CR18","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.euf.2016.12.011","volume":"4","author":"A Naselli","year":"2018","unstructured":"Naselli A, Hurle R, Paparella S, Buffi NM, Lughezzani G, Lista G et al (2018) Role of restaging transurethral resection for T1 Non-muscle invasive bladder cancer: A systematic review and Meta-analysis. Eur Urol Focus Juill 4(4):558\u2013567","journal-title":"Eur Urol Focus Juill"},{"issue":"4","key":"6170_CR19","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/JU.0000000000003846","volume":"211","author":"JM Holzbeierlein","year":"2024","unstructured":"Holzbeierlein JM, Bixler BR, Buckley DI, Chang SS, Holmes R, James AC et al (2024) Diagnosis and treatment of Non-Muscle invasive bladder cancer: AUA\/SUO guideline: 2024 amendment. J Urol Avr 211(4):533\u2013538","journal-title":"J Urol Avr"},{"issue":"1","key":"6170_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.eururo.2023.08.016","volume":"85","author":"J Alfred Witjes","year":"2024","unstructured":"Alfred Witjes J, Max Bruins H, Carri\u00f3n A, Cathomas R, Comp\u00e9rat E, Efstathiou JA et al (2024) European association of urology guidelines on Muscle-invasive and metastatic bladder cancer: summary of the 2023 guidelines. Eur Urol Janv 85(1):17\u201331","journal-title":"Eur Urol Janv"},{"issue":"6","key":"6170_CR21","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1111\/bju.16471","volume":"134","author":"MJ Remmelink","year":"2024","unstructured":"Remmelink MJ, Rip Y, Nieuwenhuijzen JA, Ket JCF, Oddens JR, de Reijke TM et al (2024) Advanced optical imaging techniques for bladder cancer detection and diagnosis: a systematic review. BJU Int d\u00e9c 134(6):890\u2013905","journal-title":"BJU Int d\u00e9c"},{"issue":"14","key":"6170_CR22","doi-asserted-by":"publisher","first-page":"23880","DOI":"10.18632\/oncotarget.13054","volume":"8","author":"W Kang","year":"2017","unstructured":"Kang W, Cui Z, Chen Q, Zhang D, Zhang H, Jin X (2017) Narrow band imaging-assisted transurethral resection reduces the recurrence risk of non-muscle invasive bladder cancer: a systematic review and meta-analysis. Oncotarget 4 Avr 8(14):23880\u201323890","journal-title":"Oncotarget 4 Avr"},{"key":"6170_CR23","doi-asserted-by":"crossref","unstructured":"Russo GI, Sholklapper TN, Cocci A, Broggi G, Caltabiano R, Smith AB et al (2021) Performance of Narrow Band Imaging (NBI) and Photodynamic Diagnosis (PDD) Fluorescence Imaging Compared to White Light Cystoscopy (WLC) in Detecting Non-Muscle Invasive Bladder Cancer: A Systematic Review and Lesion-Level Diagnostic Meta-Analysis. Cancers. 30 ao\u00fbt. ;13(17):4378","DOI":"10.3390\/cancers13174378"},{"issue":"5","key":"6170_CR24","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.euo.2023.07.010","volume":"6","author":"D D\u2019Andrea","year":"2023","unstructured":"D\u2019Andrea D, Soria F, Hurle R, Enikeev D, Kotov S, R\u00e9gnier S et al (2023) En bloc versus conventional resection of primary bladder tumor (eBLOC): A Prospective, Multicenter, Open-label, phase 3 randomized controlled trial. Eur Urol Oncol Oct 6(5):508\u2013515","journal-title":"Eur Urol Oncol Oct"},{"issue":"5\u20136","key":"6170_CR25","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1159\/000503734","volume":"104","author":"H Yang","year":"2020","unstructured":"Yang H, Lin J, Gao P, He Z, Kuang X, Li X et al (2020) Is the En bloc transurethral resection more effective than conventional transurethral resection for Non-Muscle-Invasive bladder cancer? A systematic review and Meta-Analysis. Urol Int 104(5\u20136):402\u2013409","journal-title":"Urol Int"},{"issue":"4","key":"6170_CR26","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.euo.2025.06.003","volume":"8","author":"PE Gabriel","year":"2025","unstructured":"Gabriel PE, Roumigui\u00e9 M, Marcq G, Allory Y, Audenet F, Bajeot AS et al (2025) The evolving landscape of systemic immunotherapy for Bacillus Calmette-Gu\u00e9rin-na\u00efve High-risk Non-muscle-invasive bladder cancer: at the edge of a tsunami? Eur Urol Oncol ao\u00fbt 8(4):1174\u20131181","journal-title":"Eur Urol Oncol ao\u00fbt"},{"issue":"8","key":"6170_CR27","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1038\/s41591-025-03738-z","volume":"31","author":"ND Shore","year":"2025","unstructured":"Shore ND, Powles TB, Bedke J, Galsky MD, Palou Redorta J, Ku JH et al (2025) Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial. Nat Med 31 Aout 31(8):2806\u20132814","journal-title":"Nat Med 31 Aout"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-06170-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-025-06170-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-06170-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:09:33Z","timestamp":1768342173000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-025-06170-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6170"],"URL":"https:\/\/doi.org\/10.1007\/s00345-025-06170-7","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]},"assertion":[{"value":"7 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"84"}}